Introduction Pharma tenders have evolved; they’re not just about the lowest price anymore. Hospitals, governmen...
Introduction Injectable manufacturing is a high-risk decision for companies to outsource to suppliers in the pharmace...
Introduction A significant portion of the highest-value and highest-risk products in pharmaceutical manufacturing is...
Introduction The private label (OEM/ODM) model for nutraceutical manufacturing allows companies to quickly introduce...
Introduction As pharmaceutical companies expand into multiple markets and face ever-growing complexities in their reg...
Introduction Worldwide compliance for pharmaceutical supply chains continues to grow and change, as a result the cont...
Introduction Asia's nutraceutical and dietary supplement industry is experiencing tremendous growth. This growth...
Introduction In 2026, API pricing for global buyers will no longer be based only on manufacturing costs. Factors such...
Introduction Latin America is continuously evolving and growing in the field of pharmaceuticals. Due to the increasin...
On January 3, 2026, U.S. military forces took control of Venezuelan President Nicolás Maduro through a military i...
Introduction In the year 2026, global sourcing of active pharmaceutical ingredients (APIs) has transformed into a hig...
Executive Summary For the global B2B pharmaceutical ecosystem, the year 2025 is seen as critical for both COVID-relat...
Stay updated on pharma trends and marketplace opportunities.